nodes	percent_of_prediction	percent_of_DWPC	metapath
Nepafenac—PTGS2—Barrett's esophagus	0.795	1	CbGaD
Nepafenac—Dry eye syndrome—Esomeprazole—Barrett's esophagus	0.0324	0.192	CcSEcCtD
Nepafenac—Dry eye syndrome—Omeprazole—Barrett's esophagus	0.0324	0.192	CcSEcCtD
Nepafenac—Lacrimation decreased—Omeprazole—Barrett's esophagus	0.0186	0.11	CcSEcCtD
Nepafenac—Lacrimation decreased—Esomeprazole—Barrett's esophagus	0.0186	0.11	CcSEcCtD
Nepafenac—Visual acuity reduced—Omeprazole—Barrett's esophagus	0.00513	0.0304	CcSEcCtD
Nepafenac—Visual acuity reduced—Esomeprazole—Barrett's esophagus	0.00513	0.0304	CcSEcCtD
Nepafenac—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGES—Barrett's esophagus	0.00492	0.173	CbGpPWpGaD
Nepafenac—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGES—Barrett's esophagus	0.00391	0.138	CbGpPWpGaD
Nepafenac—Eye irritation—Esomeprazole—Barrett's esophagus	0.00358	0.0212	CcSEcCtD
Nepafenac—Eye irritation—Omeprazole—Barrett's esophagus	0.00358	0.0212	CcSEcCtD
Nepafenac—PTGS1—Eicosanoid Synthesis—PTGES—Barrett's esophagus	0.0032	0.113	CbGpPWpGaD
Nepafenac—Blood pressure increased—Omeprazole—Barrett's esophagus	0.00305	0.0181	CcSEcCtD
Nepafenac—Blood pressure increased—Esomeprazole—Barrett's esophagus	0.00305	0.0181	CcSEcCtD
Nepafenac—Dry eye—Omeprazole—Barrett's esophagus	0.00282	0.0167	CcSEcCtD
Nepafenac—Dry eye—Esomeprazole—Barrett's esophagus	0.00282	0.0167	CcSEcCtD
Nepafenac—PTGS2—Eicosanoid Synthesis—PTGES—Barrett's esophagus	0.00254	0.0894	CbGpPWpGaD
Nepafenac—Arthritis—Omeprazole—Barrett's esophagus	0.00228	0.0135	CcSEcCtD
Nepafenac—Arthritis—Esomeprazole—Barrett's esophagus	0.00228	0.0135	CcSEcCtD
Nepafenac—PTGS1—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.00178	0.0626	CbGpPWpGaD
Nepafenac—Sinusitis—Esomeprazole—Barrett's esophagus	0.0016	0.0095	CcSEcCtD
Nepafenac—Sinusitis—Omeprazole—Barrett's esophagus	0.0016	0.0095	CcSEcCtD
Nepafenac—Eye disorder—Omeprazole—Barrett's esophagus	0.00143	0.0085	CcSEcCtD
Nepafenac—Eye disorder—Esomeprazole—Barrett's esophagus	0.00143	0.0085	CcSEcCtD
Nepafenac—PTGS2—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.00141	0.0497	CbGpPWpGaD
Nepafenac—Immune system disorder—Omeprazole—Barrett's esophagus	0.00139	0.00821	CcSEcCtD
Nepafenac—Immune system disorder—Esomeprazole—Barrett's esophagus	0.00139	0.00821	CcSEcCtD
Nepafenac—Vision blurred—Esomeprazole—Barrett's esophagus	0.00126	0.00746	CcSEcCtD
Nepafenac—Vision blurred—Omeprazole—Barrett's esophagus	0.00126	0.00746	CcSEcCtD
Nepafenac—Hypertension—Omeprazole—Barrett's esophagus	0.00115	0.00683	CcSEcCtD
Nepafenac—Hypertension—Esomeprazole—Barrett's esophagus	0.00115	0.00683	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.00113	0.00669	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.00113	0.00669	CcSEcCtD
Nepafenac—Dry mouth—Omeprazole—Barrett's esophagus	0.00111	0.00659	CcSEcCtD
Nepafenac—Dry mouth—Esomeprazole—Barrett's esophagus	0.00111	0.00659	CcSEcCtD
Nepafenac—Nervous system disorder—Omeprazole—Barrett's esophagus	0.00107	0.00633	CcSEcCtD
Nepafenac—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.00107	0.00633	CcSEcCtD
Nepafenac—Skin disorder—Omeprazole—Barrett's esophagus	0.00106	0.00627	CcSEcCtD
Nepafenac—Skin disorder—Esomeprazole—Barrett's esophagus	0.00106	0.00627	CcSEcCtD
Nepafenac—Diclofenac—CXCL8—Barrett's esophagus	0.00105	0.137	CrCbGaD
Nepafenac—PTGS2—Signaling mediated by p38-alpha and p38-beta—SLC9A1—Barrett's esophagus	0.00103	0.0361	CbGpPWpGaD
Nepafenac—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—Barrett's esophagus	0.000966	0.034	CbGpPWpGaD
Nepafenac—PTGS1—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000944	0.0333	CbGpPWpGaD
Nepafenac—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.000941	0.00558	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.000941	0.00558	CcSEcCtD
Nepafenac—Ketoprofen—CXCL8—Barrett's esophagus	0.000931	0.121	CrCbGaD
Nepafenac—Ketorolac—PTGS2—Barrett's esophagus	0.000864	0.112	CrCbGaD
Nepafenac—Bromfenac—PTGS2—Barrett's esophagus	0.000828	0.108	CrCbGaD
Nepafenac—Hypersensitivity—Omeprazole—Barrett's esophagus	0.000803	0.00476	CcSEcCtD
Nepafenac—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.000803	0.00476	CcSEcCtD
Nepafenac—Pruritus—Esomeprazole—Barrett's esophagus	0.000771	0.00457	CcSEcCtD
Nepafenac—Pruritus—Omeprazole—Barrett's esophagus	0.000771	0.00457	CcSEcCtD
Nepafenac—PTGS1—Overview of nanoparticle effects—PTGS2—Barrett's esophagus	0.000757	0.0266	CbGpPWpGaD
Nepafenac—PTGS1—Overview of nanoparticle effects—CXCL8—Barrett's esophagus	0.000734	0.0258	CbGpPWpGaD
Nepafenac—Dizziness—Esomeprazole—Barrett's esophagus	0.00072	0.00427	CcSEcCtD
Nepafenac—Dizziness—Omeprazole—Barrett's esophagus	0.00072	0.00427	CcSEcCtD
Nepafenac—Tiaprofenic acid—PTGS2—Barrett's esophagus	0.000704	0.0916	CrCbGaD
Nepafenac—Vomiting—Esomeprazole—Barrett's esophagus	0.000693	0.00411	CcSEcCtD
Nepafenac—Vomiting—Omeprazole—Barrett's esophagus	0.000693	0.00411	CcSEcCtD
Nepafenac—Headache—Omeprazole—Barrett's esophagus	0.000683	0.00405	CcSEcCtD
Nepafenac—Headache—Esomeprazole—Barrett's esophagus	0.000683	0.00405	CcSEcCtD
Nepafenac—Magnesium salicylate—PTGS2—Barrett's esophagus	0.000655	0.0851	CrCbGaD
Nepafenac—Nausea—Omeprazole—Barrett's esophagus	0.000647	0.00384	CcSEcCtD
Nepafenac—Nausea—Esomeprazole—Barrett's esophagus	0.000647	0.00384	CcSEcCtD
Nepafenac—Fenbufen—PTGS2—Barrett's esophagus	0.000641	0.0833	CrCbGaD
Nepafenac—PTGS1—Eicosanoid Synthesis—PTGS2—Barrett's esophagus	0.000628	0.0221	CbGpPWpGaD
Nepafenac—PTGS2—Overview of nanoparticle effects—CXCL8—Barrett's esophagus	0.000583	0.0205	CbGpPWpGaD
Nepafenac—Salsalate—PTGS2—Barrett's esophagus	0.000557	0.0724	CrCbGaD
Nepafenac—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—Barrett's esophagus	0.000525	0.0185	CbGpPWpGaD
Nepafenac—PTGS1—Biological oxidations—CYP26A1—Barrett's esophagus	0.000502	0.0177	CbGpPWpGaD
Nepafenac—Fenoprofen—PTGS2—Barrett's esophagus	0.00046	0.0598	CrCbGaD
Nepafenac—Mefenamic acid—PTGS2—Barrett's esophagus	0.000427	0.0555	CrCbGaD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—Barrett's esophagus	0.000352	0.0124	CbGpPWpGaD
Nepafenac—PTGS1—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.000349	0.0123	CbGpPWpGaD
Nepafenac—Diclofenac—PTGS2—Barrett's esophagus	0.000307	0.0399	CrCbGaD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—RELA—Barrett's esophagus	0.000305	0.0107	CbGpPWpGaD
Nepafenac—Ketoprofen—PTGS2—Barrett's esophagus	0.000271	0.0353	CrCbGaD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—Barrett's esophagus	0.000269	0.00946	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000254	0.00895	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—RELA—Barrett's esophagus	0.000228	0.00805	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—PTGS2—Barrett's esophagus	0.000222	0.00782	CbGpPWpGaD
Nepafenac—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—Barrett's esophagus	0.000219	0.00772	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000202	0.00711	CbGpPWpGaD
Nepafenac—PTGS2—C-MYB transcription factor network—CDKN2A—Barrett's esophagus	0.000196	0.00689	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—RELA—Barrett's esophagus	0.000181	0.00639	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—CXCL8—Barrett's esophagus	0.000135	0.00476	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	0.000125	0.0044	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PTGES—Barrett's esophagus	0.000113	0.00399	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PTGES—Barrett's esophagus	8.99e-05	0.00316	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CYP26A1—Barrett's esophagus	8.58e-05	0.00302	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—TP53—Barrett's esophagus	8.29e-05	0.00292	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CYP26A1—Barrett's esophagus	6.81e-05	0.0024	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	6.34e-05	0.00223	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—SLC9A1—Barrett's esophagus	6.18e-05	0.00218	CbGpPWpGaD
Nepafenac—PTGS2—Disease—SLC9A1—Barrett's esophagus	5.86e-05	0.00206	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	5.64e-05	0.00199	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	5.03e-05	0.00177	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	4.99e-05	0.00176	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SLC9A1—Barrett's esophagus	4.91e-05	0.00173	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PPARG—Barrett's esophagus	2.82e-05	0.000994	CbGpPWpGaD
Nepafenac—PTGS2—Disease—APC—Barrett's esophagus	2.77e-05	0.000976	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PPARG—Barrett's esophagus	2.24e-05	0.000789	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PTGS2—Barrett's esophagus	2.22e-05	0.000782	CbGpPWpGaD
